Objectives To validate the educational needs assessment tool (The ENAT) as a generic tool for assessing the educational needs of patients with rheumatic diseases in European Countries.
Introduction
Patient education should be an integral part of the management of rheumatic diseases. [1] [2] [3] [4] It is an interactive process between patients and health care professionals aimed at enabling patients to participate actively in their health care, strengthen their ability to manage symptoms and treatment, improve coping strategies and increase self-care abilities. [5] [6] [7] It is important for health professionals to assess patient's experiential knowledge about arthritis, their own expectations, educational needs and priorities before providing education. This will help to tailor education to individual needs, and promote shared decision-making, which are important in helping patients to manage their illness and maintain quality of life. [8] [9] [10] The educational needs assessment tool (ENAT) is a self-completed questionnaire, which allows patients with arthritis to prioritise their educational needs. If completed immediately before the consultation, the health professional is able to provide education based on the patient's immediate priorities. 11 It was developed by people with arthritis and their practitioners in the UK, and comprises 39 items grouped into seven domains: managing pain (six items), movement (five items), feelings (four items), disease process (seven items), treatments (seven items), self-help measures (six items) and support systems (four items). Items are completed by the use of Likert scales ranging from 1 -'not important at all' to 5 -'extremely important'. Early research found the ENAT to be acceptable to patients, easy to complete and having good test-retest reliability. 11 The ENAT was further validated using Rasch analysis where it demonstrated a good fit to the Rasch model indicating a good construct validity and invariance to gender, age, disease duration and educational background. 12 In order to extend its use to European countries and allow multinational comparison of educational needs of people with rheumatoid arthritis (RA), the ENAT was adapted for use in six other European countries;
(Finland, The Netherlands, Norway, Portugal, Spain and Sweden) and was found to have crosscultural validity and invariance with some adjustments required for The Netherlands. 13 Since the ENAT was intended to be a generic measure across rheumatic diseases, further work was undertaken in the UK to validate it in other major rheumatic diseases, that is ankylosing spondylitis (AS), psoriatic arthritis (PsA), systemic sclerosis (SSc), systemic lupus erythematosus (SLE), osteoarthritis (OA) and fibromyalgia syndrome (FMS). 14 The aim of this study was to validate the ENAT as a generic tool with which to assess the educational needs of patients with rheumatic diseases in seven European countries.
Methods

Study design and patients
This was a multicentre European collaborative study, funded by a research grant from European League Against Rheumatism (EULAR grant reference HPR011). It followed a cross-sectional survey design, requiring patient completion of the translated versions of the ENAT on one occasion and testing its cross-cultural validity using Rasch analysis. The study was led from the University of Leeds (UK) and involved seven European countries; Austria, Finland, The Netherlands, Norway, Portugal, Spain and Sweden. The methods were set out a priori in the study protocol (unpublished), and all collaborating centres obtained ethical approvals from their respective countries before undertaking the study.
Convenience sampling was used to recruit patients from rheumatology outpatient clinics, day units, in-patient wards, databases, rehabilitation centres and/or from the community in the collaborating countries. The inclusion criteria were: (i) positive diagnosis of the target diseases (AS, PsA, SSc, SLE, OA or FMS) (ii) aged 18 years or above and (iii) willingness and ability to complete and return a questionnaire. The exclusion criteria were (i) inability to complete the ENAT unaided, (ii) having more than one form of rheumatic disease and (iii) having mental impairment.
Measures
The cross-cultural adaptation of the original (English) ENAT into the respective European languages was previously undertaken in RA, 13 using an established process for cross-cultural adaptation of selfreport measures. 15 The process involved five steps: (1) forward translation -from English into the target language, (2) synthesis of the translations; (3) back (blind) translation into the original (English) language; (4) expert committee review which decided on equivalence between the source and target versions; and (5) test of the pre-final version -testing the "adapted" version with 30 patients. Due to inclusion of different diagnostic groups in the present study, it was agreed in the set-up meeting, to use the term 'rheumatic disease' for inflammatory arthritis and connective tissue disease groups, and keep 'arthritis' for people with OA. However, in other countries such as Portugal and Spain, the term "rheumatic disease" was used for all diseases, including OA. This is because in those countries the term "arthritis" implies the presence on synovitis/effusion; and OA is also a rheumatic disease and recognised by patients and health care professionals as such (albeit degenerative rather than inflammatory).
The translated versions of the ENAT were given to patients in their respective countries to complete as postal surveys or before their clinic consultations or at the beginning of their rehabilitation programme. The ENATs were anonymous but contained patients' demographical data such as gender, age, educational background and self-reported disease duration. Once completed, the ENATs were sent by post to the University of Leeds for analysis. The ENAT data were then entered into a database (IBM SPSS, version 19) 16 and were subjected into Rasch analysis using RUMM2020 17 software.
Data analysis
Rasch analysis is a mathematical modelling technique used to assess properties of outcome measures against a measurement model developed by the Danish mathematician Georg Rasch. 18 The Rasch model provides a formal representation of fundamental measurement, and in Rasch analysis the observed data from questionnaires are measured against the Rasch model to assess how well they 'fit' the model. Fit to the model implies a criterion-related construct validity, reliability and statistical sufficiency. [19] [20] [21] Further details of Rasch Analysis tests of fit are published elsewhere. 22 All ENAT items were assessed individually and collectively for fit to the model, testing for the assumption of local independence of items and the overall fit. Local independence means that items that fit the Rasch model are expected to be independent of each other, that is, there should not be any correlation between two items after the effect of the underlying construct is conditioned out. 23 In the analysis, the items that were found to be locally dependent (a correlation of ±0.3 being the threshold for local dependency) 24 were combined into a subtest and treated as a 'testlet', which is defined as a subset of items that is treated as a measurement unit in test construction, administration and/or scoring. 25 The data from each diagnostic group from each country were tested for the overall fit to the Rasch model and differential item functioning (DIF) by gender, age, disease duration and educational background. DIF occurs when two groups of equal ability levels are not equally able to correctly answer an item. If the factor leading to DIF is not part of the construct being tested, then the item is biased, that is, observed scores should depend only on latent construct scores, and not on group membership or occasion. [26] [27] [28] [29] It is important to identify the biased items, so that adjustments can be made, which may sometimes involve discarding the item. 29 To allow for group comparisons, age and disease duration, which are continuous data, were converted into categorical data by splitting at the medians. Educational background was simply categorised as: those with only compulsory (basic) education and those with further education. Group comparisons tested the assumption of invariance (absence of DIF) of the ENAT across all patient subgroups, that is age groups, gender, disease duration and educational background. Following country-specific analyses, the data was pooled in each disease group and fit to the Rasch model was assessed. The pooled data were additionally tested for DIF by culture (cross-cultural bias). Where cross-cultural DIF was found, a post-hoc (Tukey test) was performed to assess where the significant difference lies, and the biased items were adjusted for the using the method described by Tennant et al 29 and Brodersen et al. 28 The overall fit statistics are reported as c 2 probability, where p-value is expected to be nonsignificant for adequate fit to the model. In most analyses, the p-values were Bonferroni-adjusted to the alevel (ie, p = 0.05/number of tests carried out), to avoid type I errors due to multiple testing. 30 Reliability is reported as Person Separation Index (PSI), which estimates the internal consistency of the scale equivalent to Cronbach's a, only using the logit value as opposed to the raw score in the same formulae. A minimum value of 0.7 is required for group use and 0.85 for individual use. 22 Following fit to the Rasch model, the test of strict unidimensionality of the ENAT was conducted using the t-test method suggested by Smith, 31 where unidimensionality is confirmed if less than 5% of independent t-tests on the latent estimates derived from two independent sets of items lie outside the ±1.96 range. The ENATs were then calibrated into an interval-level scale to allow for Raschtransformation of the ordinal data into interval level data when required. 32
Results
A total of 3219 patients were recruited in this study. In all, 74 patients with undifferentiated spondyloarthropathy from Sweden and 130 with RA from Austria were excluded from the analysis, as these diagnostic groups were not included in the protocol. This meant that data from 3015 patients were analysed. Patient characteristics (stratified by diagnostic group) were comparable across countries except for educational background, which was variable. Table 1 summarises the countryspecific gender distribution, mean age, disease duration, educational background and the availability of data in each diagnostic group. The data from each diagnostic group and country were fitted to the Rasch model separately ( Table 2) and then they were pooled into diagnostic group datasets (Table 3 ). In most diagnostic groups (AS, PsA, SSc and SLE), the five response categories (Likert scales) were found to work as expected. The preliminary analysis of the individual 39 items resulted in significant deviation from the Rasch model, that is, the p values of the c 2 interaction were significant in all disease groups ( Lack of fit to the model was caused by significant correlations of items within each domains (a residual correlation of ±0.3 being the threshold for local dependency). 24 Correction for local dependency involved grouping the 39 items into their respective seven domains (ie, pain, movement, feelings, disease process, treatments, self-help and support) and scoring the ENAT as a 'seven-testlet'
scale. Fit to the Rasch model was achieved in all country-specific data following correction for local dependency with the exception of the OA disease group from Portugal. In all country-specific datasets, the internal consistency was high (PSI>0.88 -PSI of 0.7 is required for group use) ( Table 2: Analysis 2). These results mean that the domain (subscale) scores of the ENAT can be summed up to
give a total score. In each pooled (diagnostic-specific) data, fit to Rasch model was also satisfied, with the exception of the OA dataset (Table 3 ). In all pooled analyses, person separation index (PSI) was greater than 0.93 indicating an excellent reliability (internal consistency) for both group and individual uses. Strict unidimensionality of the overall scale was confirmed in all disease groups except in the AS and PsA diagnostic groups in which the proportions of significant t-tests (95%CI) were 0.074 (0.058, 0.092) and 0.071 (0.056, 0.086) respectively, indicating a small degree of multidimensionality. Post-hoc analyses that followed later ( Table 4) , suggested this to be caused by cross-cultural DIF. A formal assessment of invariance (DIF analysis) was performed in the diagnostic groups that satisfied the Rasch model requirements (AS, PsA, SSc, SLE and FMS). There was no significant DIF by gender, age, disease duration or educational background in the country specific datasets. This suggests that the ENAT is not biased by person characteristics. However, in the pooled datasets, DIF by culture was detected across the diagnostic groups indicating a cross-cultural bias especially in the PsA disease group (Table 4 ). Adjustments were made in the biased items to account for the cross-cultural DIF. This involved 'splitting' the biased item into two; where one is rendered unique for the affected country and the other for the rest of the countries. For example in the AS disease group ( Table 5) , there are two pain testlets, one unique for Norway and the other for the rest of the countries. The unsplit (pure) items act as links in the calibration of the scale thus discounting the cross-cultural bias. 28, 29 Following this adjustment, the resulting testlets were found to adequately fit the model ( Table 5 ). This means that the ENAT can be used in its present form within each country without any need for adjustments.
However, when data across countries are being pooled or compared, then adjustment for crosscultural DIF will be required. We have calibrated DIF-adjusted interval-level scales for this purpose (see online supplementary tables 1-14). Following adjustment to the cross-cultural DIF (in the AS, PsA, SSc and SLE diagnostic groups), the raw ENAT domain scores were mapped against the corresponding Rasch-transformed scores (based in logits) and were linearly transformed to calibrate interval-level, DIF-adjusted scales of the same range (see online supplementary tables [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . The details on the use and scoring of the ENAT are given in the online supplementary material.
Discussion
This study set out to test the cross-cultural validity of the ENAT as a generic measure of educational needs in people with AS, PsA, SSc, SLE, OA and FMS in different European countries. The results indicate that, following its adaptation; the ENAT maintained its validity in each disease group that was tested (with limitations in OA). The implications of the results in terms of clinical use and measurement aspects are set out below.
In the clinical practice, the ENAT is used as a template/checklist to assess what are the most important educational/informational needs from the patient's point of view. Patients using the ENAT have consistently found it easy to complete and effective in identifying their needs and raise questions which they would not have otherwise considered. 12, 33 domains. This was also seen in a similar study in RA. 13 Correction for this may involve removing the redundant items or grouping all the locally-dependent items into a testlet (hence scoring them as a unit). We used the 'testlet' approach as it helps to retain the clinically relevant items, yet meeting the measurement requirements of the scale. This approach to scoring is similar to that used in other scales such as the HAQ 34 and the HADs. 35 While the ENAT was invariant to person characteristics, some items worked differently in some countries especially in the OA and SpA disease groups. Therefore, when the data across different have been used to assess to its correlation with disease activity and disability in RA and PsA. 37 While the ENAT remains a valid country-specific measure of education needs for people with OA, strong conclusions cannot be made about its cross-cultural validity, which warrants further research.
One of the reasons for the lack of fit in this group may be the inherent heterogeneous nature of OA, where educational needs of patients with hand OA may be different from those of patients with hip or knee OA. This implies that when assessing the educational needs of people with OA, the data from different countries should not be pooled until their cross-cultural validity has been established.
This study has four main limitations. First, in most countries the data were collected from limited sources and therefore not representative of the countries involved. However, this does not affect the conclusions of this tool validation research, as this research did not set out to assess the educational needs but rather to determine the validity of the ENAT and its psychometric properties following its adaptation. Second, not all disease groups were represented in each country. Therefore the results apply only in the available disease groups. Third, being a cross-sectional study, the ENAT's stability to change has not been established. However, given the nature of needs assessment, it is difficult to 
Conclusion
This study has established that the ENAT is a valid and a reliable tool, providing an accurate measure of educational needs for people with rheumatic diseases. While clinical use of the ENAT as a simple checklist does not require scoring, its interval-level scale provides estimates that can be used alongside other variables in parametric analyses. In addition, a facility is available for cross-cultural comparisons when required. Further research is required in its use in electronic formats and development as a computerised adaptive assessment.
